Learn about Vanderbilt’s CTSA and how it supports VICTR’s mission

About the Vanderbilt CTSA

The first CTSA’s were awarded to 12 academic medical centers in September 2006. Vanderbilt’s CTSA was funded during the second round of awards in September of 2007.

Now fully implemented, the CTSA Consortium includes about 60 of the leading academic institutions across the nation, linked together by this massive NIH endeavor.

Each CTSA is led by a principal investigator, an established clinician scientist, who has the primary responsibility to define objectives and approaches of the CTSA and to oversee the CTSA at a local level as well as collaborate with the national CTSA consortium.

Vanderbilt’s CTSA principal investigator and program director is Gordon R. Bernard, M.D. Dr. Bernard is also the director of The Vanderbilt Institute for Clinical and Translational Research (VICTR).

Click on the links below to read announcements about the Vanderbilt CTSA:

The Report: Vanderbilt's CTSA lands $46 million renewal

The Reporter: Clinical Research Gets Massive Boost

Promoting Translational Research at Vanderbilt University's CTSA Institute

Questions, Comments, Suggestions...

Ask a question about VICTR or the CTSA
or provide comments or suggestions
regarding this website. Include your name and address if you wish to receive a response.

Type characters above to submit